W has the potential to cause mild to severe immediate or delayed haemolytic transfusion reactions there is currently limited literature related to the best transfusion management of this patients. We report different approaches to successful transfusion care of two patients with chronic renal failure with established anti-C W after they were transfused with Rh and Kell blood group phenotype-compatible RBCs units. Anti-human globulin cross-match was used to find compatible blood units in case with single antibody. For patient with multiple antibodies, screening for C W antigen-negative RBCs units was included in pretransfusion testing.
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. Anti-CW is usually of the IgG type and has the potential to cause mild to severe immediate or delayed hemolytic transfusion reactions and mild to moderate hemolytic disease of newborns [2] Assessing clinical significance of antibodies and selecting compatible blood products for patients is a challenge [3] . Standard transfusion practice in the world to find compatible blood for patients with confirmed presence of anti-C W relies on a negative anti-human globulin (AHG) cross-matches or on typing RBCs units for C W Ag [4, 5] . We present both cases. The aim of this report is to add our experience to currently limited literature related to the best transfusion management of this patients. Hemolytic reactions did not occurre in both patients. Patients were labeled as patients with detected antibodies.
CASE REPORT
This cases of allosensibilization with established anti-C W (one case with single and other with multiple RBCs antibodies) represent two different approaches to successful transfusion care of these patients. AHG cross-match was used to determine compatibility in the presence of antibodies to this low frequency antigen. For patient with multiple antibodies, screening for antigen-negative RBCs units was included in pretransfusion testing.
In the world the percentage of alloimmunized patients ranges from 1-6% after single transfusion to more than 30% at multitransfused patients [6] [7] [8] Many studies have demonstrated that alloimmunization to RBCs antigens occurs in a higher percentage among these patients than in the general population [9, 10] .
Transfusion support of these patients has been influenced by several factors: urgency of transfusion; clinical conditions requiring multiple transfusions; probability of an immune response to other RBCs antigens; potential clinical significance of the antibody; grading of the IAT cross-match reactions (less than 3 on a scale of 0-5). Compatible blood units were used within the blood stock (the phenotype status has been tested or retrieved from database) or blood donors with known phenotype were invited. Blood units from other transfusion centers were also available.
Although C W Ag has a low incidence in the population and C W Ag -negative blood is widely available, physician must be aware that the occurrence of anti-C W can lead to serious transfusion complications. The present case shows two patients with anti-C W successfuly monitored and treated with transfusions. The emphasis is put on the individual approach to pretransfusion testing and use of phenotypically matched RBCs for these patients in order to establish the best practice and to increase the blood safety.
